Abstract: A system for accessing vehicle sensor data. The system includes receiving vehicle sensor data and a vehicle location associated with the vehicle sensor data from a publisher vehicle. A subscriber request for remote data is received from a service subscriber. The subscriber request includes a request location. A match condition is determined. The match condition includes a vehicle location match between the request location and the vehicle location. The vehicle sensor data is transmitted to the service subscriber upon the occurrence of the match condition.

Abstract: The present invention relates to silk fibroin bioinks specifically formulated for use in 3D bioprinting and the production of ex-vivo models capable of supporting hematopoiesis and the production of platelets and blood cells.

Abstract: A circuit arrangement includes a preprocessing circuit configured to obtain context information related to a user location, a learning circuit configured to determine a predicted user movement based on context information related to a user location to obtain a predicted route and to determine predicted radio conditions along the predicted route, and a decision circuit configured to, based on the predicted radio conditions, identify one or more first areas expected to have a first type of radio conditions and one or more second areas expected to have a second type of radio conditions different from the first type of radio conditions and to control radio activity while traveling on the predicted route according to the one or more first areas and the one or more second areas.

Abstract: The disclosure generally pertains to systems and methods for providing a delivery assistance service having an augmented-reality digital companion (ARDC). In an example method, a first set of instructions can be received via the ARDC. The first set of instructions can direct a delivery driver to an assigned delivery vehicle within a parking lot. A second set of instructions including a driving destination can be received via the ARDC. When the delivery driver has reached the driving destination, a third set of instructions can be received via the ARDC. The third set of instructions can include a route from the driving destination to a delivery location. When the delivery driver is traveling along the route, first pop-up information can be provided via the ARDC. The delivery request can be completed, and second pop-up information can be provided via the ARDC to assist the delivery driver in reaching an intended destination.

Abstract: This disclosure is generally directed to systems and methods for providing a software sensor in a vehicle. In an example embodiment, a determination is made regarding the availability of a feature upgrade to a vehicle and a request may be made (to a cloud computer, for example), for obtaining the feature upgrade. The cloud computer provides an emulation software module based on emulating a first sensor that is unavailable in the vehicle. The feature upgrade may be installed in the vehicle by executing the emulation software module and by use of a second sensor that is available in the vehicle. In an example implementation, the second sensor available in the vehicle is a type of hardware sensor such as, for example, a camera, and the first sensor that is emulated is a different type of hardware sensor such as, for example, an air quality sensor.

Abstract: In certain aspects, the disclosure relates to anti-idiotype antibodies and antigen-binding portions thereof that specifically bind a GP5B83 containing protein, e.g., an antibody or antigen-binding portions thereof. In some aspects, the anti-idiotype antibodies and antigen-binding portions of the present disclosure can be used in methods to detect and quantify cells expressing chimeric antigen receptors that include GP5B83.

Abstract: Systems and methods are disclosed for computing an optimized delivery route for a delivery vehicle based on package information. Example methods may include receiving a plurality of delivery fulfillment requests from at least one client platform, each delivery fulfillment request including a delivery location, selecting a set of requests from the received delivery fulfillment requests, each request within the set including a delivery location within a same geographical region, assigning the selected set of requests to a delivery vehicle based on capacity information for the delivery vehicle and package information for each package which is to be delivered by the delivery vehicle, computing a preliminary delivery route for the delivery vehicle based on the delivery locations of the delivery fulfillment requests within the selected set, computing an optimized delivery route for the preliminary delivery route based on the package information, and dispatching the optimized delivery route to the delivery vehicle.

Abstract: The present invention relates to antibodies that broady neutralize interferon-? and interferon-?, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Abstract: A computer-implemented method for automatically analyzing a natural language input for information extraction comprises (i) a step of receiving the natural language input; (ii) a step of providing a grammar model comprising: a local grammar model, a set of external functions, and a finite set of read/write shared memory registers used by a parsing engine and the external functions; (iii) a step of applying the grammar model to the natural language input using the parsing engine, and (iv) a step of extracting information from the natural language input using at least one new output of the grammar model, the new output of the grammar model being built based: on at least one return value of the external functions from evaluating the one or more external functions in step (iii), and one or more input labels and/or output labels.

Abstract: The present invention relates to antibodies that broady neutralize interferon-? and interferon-?, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Abstract: The present invention relates to antibodies that broady neutralize interferon-? and interferon-?, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Abstract: Broadly neutralizing interferon-? and interferon-? antibody antagonists, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are usefule in the treatment of diseases associated with increased production of IFN? and IFN?.

Abstract: The present invention relates to antibodies that broady neutralize interferon-? and interferon-?, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Abstract: The present invention relates to antibodies that broady neutralize interferon-? and interferon-?, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Abstract: Broadly neutralizing interferon-? and interferon-? antibody antagonists, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of diseases associated with increased production of IFN? and IFN?.

Abstract: The present invention relates antibodies or antigen-binding fragments thereof specifically binding HLA-DR, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Abstract: Broadly neutralizing interferon-? and interferon-? antibody antagonists, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of diseases associated with increased production of IFN? and IFN?.

Abstract: Broadly neutralizing interferon-? and interferon-? antibody antagonists, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing are useful in the treatment of diseases associated with increased production of IFN? and IFN?.

Abstract: The present invention relates to antibodies that broady neutralize interferon-? and interferon-?, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Abstract: The invention relates to a humanized form of an antibody capable of preventing tissue factor (coagulation factor F3) signaling but which does not interfere with Factor VII binding or FX binding to tissue factor and does not prolong coagulation time. The antibody of the invention is useful in treating conditions, such as tumor progression, in which the associated cells express tissue factor and tissue factor signaling occurs.